The EPS projection of Compugen Ltd. (NASDAQ:CGEN) for quarter ended 2016-09-30 is $-0.17. Last week, the EPS forecast was $-0.17 against target of $-0.17, a month earlier. Two months ago, this estimate was $-0.17 versus forecast of $-0.17 three months earlier, implying a deviation of 0%.
Compugen Ltd. (NASDAQ:CGEN) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Compugen Ltd. (NASDAQ:CGEN) in the preceding 30, 120, 60 and 90 days were 0, 1, 1, and 1, correspondingly.
Compugen Ltd. (NASDAQ:CGEN) EPS target for the quarter closed 1 was $-0.17, based on 2 recommendations. As reported on 2016-05-10 the EPS was $-0.17. The change was $-0.01, implying a percentage deviation of -6.25%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Compugen Ltd. (NASDAQ:CGEN) yearly sales prediction for the fiscal 2016 stands at $3.606 and the median estimate is at $3.606. Almost 2 analysts issued sales target.
Highest sales target is $7.2 while the lowest target is $0.012 showing standard deviation of 5.082%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Compugen Ltd. (NASDAQ:CGEN) announced that the deviation in forecast was -68.953%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...